Cargando…

PFKFB2 Promoter Hypomethylation as Recurrence Predictive Marker in Well-Differentiated Thyroid Carcinomas

Despite the low mortality rates, well-differentiated thyroid carcinomas (WDTC) frequently relapse. BRAF and TERT mutations have been extensively related to prognosis in thyroid cancer. In this study, the methylation levels of selected CpGs (5-cytosine-phosphate-guanine-3) comprising a classifier, pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Camargo Barros-Filho, Mateus, Barreto Menezes de Lima, Larissa, Bisarro dos Reis, Mariana, Bette Homem de Mello, Julia, Moraes Beltrami, Caroline, Lopes Pinto, Clóvis Antonio, Kowalski, Luiz Paulo, Rogatto, Silvia Regina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471408/ https://www.ncbi.nlm.nih.gov/pubmed/30884810 http://dx.doi.org/10.3390/ijms20061334

Ejemplares similares

Loss of DNA methylation is related to increased expression of miR-21 and miR-146b in papillary thyroid carcinoma
por: Ortiz, Isabella Maria Dias Payão, et al.
Publicado: (2018)

Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors
por: Bisarro dos Reis, Mariana, et al.
Publicado: (2017)

Integrated data analysis reveals potential drivers and pathways disrupted by DNA methylation in papillary thyroid carcinomas
por: Beltrami, Caroline Moraes, et al.
Publicado: (2017)

Characterization of BRAF mutation in patients older than 45 years with well-differentiated thyroid carcinoma
por: Barreno, Luis Rene Quiroa, et al.
Publicado: (2020)

GADD45B Transcript Is a Prognostic Marker in Papillary Thyroid Carcinoma Patients Treated With Total Thyroidectomy and Radioiodine Therapy
por: Barros-Filho, Mateus C., et al.
Publicado: (2020)

Roles of PFKFB3 in cancer
por: Shi, Linlin, et al.
Publicado: (2017)

Therapeutic targeting of PFKFB3 and PFKFB4 in multiple myeloma cells under hypoxic conditions
por: Okabe, Seiichi, et al.
Publicado: (2022)

An Integrative Genomic and Transcriptomic Analysis Reveals Potential Targets Associated with Cell Proliferation in Uterine Leiomyomas
por: Cirilo, Priscila Daniele Ramos, et al.
Publicado: (2013)

HMGA2 overexpression is associated with differential expression of miRNAs in uterine leiomyomas
por: Mello, Julia BH, et al.
Publicado: (2013)

Transcription profiling in papillary thyroid carcinoma reveals potential diagnostic markers and drug targets
por: Filho, Mateus CB, et al.
Publicado: (2013)

Circulating mRNAs and miRNAs as candidate markers for the diagnosis and prognosis of prostate cancer
por: de Souza, Marilesia Ferreira, et al.
Publicado: (2017)

The metabolic role of PFKFB4 in androgen-independent growth in vitro and PFKFB4 expression in human prostate cancer tissue
por: Li, Ximing, et al.
Publicado: (2020)

Role of PFKFB3 and PFKFB4 in Cancer: Genetic Basis, Impact on Disease Development/Progression, and Potential as Therapeutic Targets
por: Kotowski, Krzysztof, et al.
Publicado: (2021)

Bannayan-Riley-Ruvalcaba syndrome with deforming lipomatous hamartomas in infant - Case report
por: Gontijo, Gabriela Maria Abreu, et al.
Publicado: (2013)

Case for diagnosis
por: Klein, Fernanda Homem de Mello de Souza, et al.
Publicado: (2013)

Role of PFKFB3-driven glycolysis in sepsis
por: Xiao, Min, et al.
Publicado: (2023)

Genomic Signatures Predict Poor Outcome in Undifferentiated Pleomorphic Sarcomas and Leiomyosarcomas
por: Silveira, Sara Martoreli, et al.
Publicado: (2013)

The influence of PFK-II overexpression on neuroblastoma patients’ survival may be dependent on the particular isoenzyme expressed, PFKFB3 or PFKFB4
por: Trojan, Sonia E., et al.
Publicado: (2019)

Organ preservation and oncological outcomes in early laryngeal cancer: a propensity score-based study
por: de Carvalho, Genival Barbosa, et al.
Publicado: (2021)

Copy number alteration signature defines undifferentiated pleomorphic sarcomas and leiomyosarcomas with poor prognosis
por: Silveira, Sara Martoreli, et al.
Publicado: (2013)

PFKFB3: A Potential Key to Ocular Angiogenesis
por: Zhou, Zi-Yi, et al.
Publicado: (2021)

Functional diversity of PFKFB3 splice variants in glioblastomas
por: Heydasch, Ulli, et al.
Publicado: (2021)

PFKFB3-mediated Pro-glycolytic Shift in Hepatocellular Carcinoma Proliferation
por: Dou, Qianhui, et al.
Publicado: (2022)

Expression of cancer/testis antigens MAGE-A, MAGE-C1, GAGE and CTAG1B in benign and malignant thyroid diseases
por: Melo, Daniel Hardy, et al.
Publicado: (2017)

Inhibition of PFKFB3 Hampers the Progression of Atherosclerosis and Promotes Plaque Stability
por: Poels, Kikkie, et al.
Publicado: (2020)

The PFKFB3 Inhibitor AZ67 Inhibits Angiogenesis Independently of Glycolysis Inhibition
por: Emini Veseli, Besa, et al.
Publicado: (2021)

PFKFB3 promotes proliferation, migration and angiogenesis in nasopharyngeal carcinoma
por: Gu, Miao, et al.
Publicado: (2017)

Tuning PFKFB3 Bisphosphatase Activity Through Allosteric Interference
por: Macut, Helena, et al.
Publicado: (2019)

PFKFB3 Inhibition Impairs Erlotinib-Induced Autophagy in NSCLCs
por: Lypova, Nadiia, et al.
Publicado: (2021)

Canonical and Non-Canonical Roles of PFKFB3 in Brain Tumors
por: Alvarez, Reinier, et al.
Publicado: (2021)

Myeloid PFKFB3-mediated glycolysis promotes kidney fibrosis
por: Yang, Qiuhua, et al.
Publicado: (2023)

Genome-wide methylation and transcriptome analysis in penile carcinoma: uncovering new molecular markers
por: Kuasne, Hellen, et al.
Publicado: (2015)

Multidimensional integrative analysis uncovers driver candidates and biomarkers in penile carcinoma
por: Marchi, Fabio Albuquerque, et al.
Publicado: (2017)

miR-22 and miR-205 Drive Tumor Aggressiveness of Mucoepidermoid Carcinomas of Salivary Glands
por: Naakka, Erika, et al.
Publicado: (2022)

PFKFB3 Control of Cancer Growth by Responding to Circadian Clock Outputs
por: Chen, Lili, et al.
Publicado: (2016)

Targeting PFKFB3 radiosensitizes cancer cells and suppresses homologous recombination
por: Gustafsson, Nina M. S., et al.
Publicado: (2018)

Targeting PFKFB3 alleviates cerebral ischemia-reperfusion injury in mice
por: Burmistrova, Olga, et al.
Publicado: (2019)

PFKFB3-mediated glycolysis rescues myopathic outcomes in the ischemic limb
por: Ryan, Terence E., et al.
Publicado: (2020)

Mutation of regulatory phosphorylation sites in PFKFB2 worsens renal fibrosis
por: Lee, Mardiana, et al.
Publicado: (2020)

The Role of HIF1α-PFKFB3 Pathway in Diabetic Retinopathy
por: Min, Jie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ibt82q7m5fi0e3rs08hp0j5fot